Literature DB >> 33673224

Cardiac Arrhythmias in Muscular Dystrophies Associated with Emerinopathy and Laminopathy: A Cohort Study.

Michał Marchel1, Agnieszka Madej-Pilarczyk2, Agata Tymińska1, Roman Steckiewicz1, Ewa Ostrowska1, Julia Wysińska1, Vincenzo Russo3, Marcin Grabowski1, Grzegorz Opolski1.   

Abstract

INTRODUCTION: Cardiac involvement in patients with muscular dystrophy associated with Lamin A/C mutations (LMNA) is characterized by atrioventricular conduction abnormalities and life-threatening cardiac arrhythmias. Little is known about cardiac involvement in patients with emerin mutation (EMD). The aim of our study was to describe and compare the prevalence and time distribution of cardiac arrhythmias at extended follow-up. PATIENTS AND METHODS: 45 consecutive patients affected by muscular dystrophy associated to laminopathy or emerinopathy were examined. All patients underwent clinical evaluation, 12-lead surface electrocardiogram (ECG), 24 h electrocardiographic monitoring, and cardiac implanted device interrogation.
RESULTS: At the end of 11 (5.0-16.6) years of follow-up, 89% of the patients showed cardiac arrhythmias. The most prevalent was atrial standstill (AS) (31%), followed by atrial fibrillation/flutter (AF/Afl) (29%) and ventricular tachycardia (22%). EMD patients presented more frequently AF/AFl compared to LMNA (50% vs. 20%, p = 0.06). Half of the EMD patients presented with AS, whilst there was no occurrence of such in the LMNA (p = 0.001). Ventricular arrhythmias were found in 60% of patients with laminopathy compared to 3% in patients with emerinopathy (p < 0.001). The age of AVB occurrence was higher in the LMNA group (32.8 +/- 10.6 vs. 25.1 +/- 9.1, p = 0.03).
CONCLUSIONS: Atrial arrhythmias are common findings in patients with muscular dystrophy associated with EMD/LMNA mutations; however, they occurred earlier in EMD patients. Ventricular arrhythmias were very common (60%) in LMNA and occurred definitely earlier compared to the EMD group.

Entities:  

Keywords:  EMD; Emery–Dreifuss muscular dystrophy; LMNA; emerin; lamin A/C

Year:  2021        PMID: 33673224     DOI: 10.3390/jcm10040732

Source DB:  PubMed          Journal:  J Clin Med        ISSN: 2077-0383            Impact factor:   4.241


  4 in total

Review 1.  Arrhythmias as Presentation of Genetic Cardiomyopathy.

Authors:  J Lukas Laws; Megan C Lancaster; M Ben Shoemaker; William G Stevenson; Rebecca R Hung; Quinn Wells; D Marshall Brinkley; Sean Hughes; Katherine Anderson; Dan Roden; Lynne W Stevenson
Journal:  Circ Res       Date:  2022-05-26       Impact factor: 23.213

Review 2.  Clinical Profile, Arrhythmias, and Adverse Cardiac Outcomes in Emery-Dreifuss Muscular Dystrophies: A Systematic Review of the Literature.

Authors:  Anna Chiara Valenti; Alessandro Albini; Jacopo Francesco Imberti; Marco Vitolo; Niccolò Bonini; Giovanna Lattanzi; Renate B Schnabel; Giuseppe Boriani
Journal:  Biology (Basel)       Date:  2022-03-30

3.  A novel mutation in human EMD gene and mitochondrial dysfunction in emerin knockdown cardiomyocytes.

Authors:  Zunhui Du; Tinfang Zhu; Menglu Lin; Yangyang Bao; Jing Qiao; Gang Lv; Yinyin Xie; Qihen Li; Jinwei Quan; Cathy Xu; Yuan Xie; Lingjie Wang; Wenjie Yang; Shengyue Wang; Liqun Wu; Tong Yin; Yucai Xie
Journal:  J Cell Mol Med       Date:  2022-09-15       Impact factor: 5.295

Review 4.  Diagnosis of Cardiac Abnormalities in Muscular Dystrophies.

Authors:  Elisabeta Bădilă; Iulia Ioana Lungu; Alexandru Mihai Grumezescu; Alexandru Scafa Udriște
Journal:  Medicina (Kaunas)       Date:  2021-05-12       Impact factor: 2.430

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.